The stock price of leading Ahmedabad-based pharmaceutical company Lincoln Pharmaceuticals has gained more than 20% in a month with high volumes. Following the 52-week and multi-year high recently, the company's share price touched a high of Rs. 413 per share on the BSE. Consequently, the market capitalisation of the company has reached near Rs 800 crore.

Over the last 5 years, the company has delivered a robust 30% CAGR in profits and high single-digit growth in sales. It has been reporting a strong operational and financial performance and has managed to double its profit margins from around 7-8% in FY17 to over 14% in FY22. According to Mr. Mahendra Patel, Managing Director, "strategic growth initiatives, product and geographical expansion, and operational efficiency are likely to contribute to its growth going forward."

The promoter group and institutional investors have been gradually increasing their stake in the company. Over the last few years, the promoter group has gradually raised its stake from 32.36 per cent in March 2020 to 46.34 percent in December 2022. Foreign institutional investors too have gradually increased their stake over the quarter and hold 1.44% as on December 2022.

In September 2021, the company acquired a plant in Mehsana, Gujarat to launch cephalosporin products. It has invested Rs 30 crore in the cephalosporin plant- including acquisition and subsequent capacity expansion using an internal source of funds. The plant is expected to contribute sales of around Rs 150 crore in the next 3 years.

• Over the last 5 years, the company has delivered a robust 30% CAGR in profits and higher single-digit growth in sales.
• Promoter Group increased stake to 46.34% as on Dec 2022 from 32.36% as on March 2020
• Foreign institutional investors too have gradually increased their stake over the quarter and hold 1.44% as on Dec 2022.
• Company invested Rs. 30 crore in cephalosporin plant — including acquisition and subsequent capacity expansion. The plant is expected to contribute sales of around Rs 150 crore in the next 3 years.
• t currently exports to 60-plus countries and plans to enter the EU markets very soon.